AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health education structured according to the health belief model
Description: After the participants enrolled in the study, the patients in the study group will be given a health education structured according to the health belief model at the first interview.
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health education structured according to the health belief model
Description: After the participants enrolled in the study, the patients in the study group will be given a health education structured according to the health belief model at the first interview.
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Training booklet prepared by the researchers on healthy lifestyle behavior changes
Description: After the participants enrolled in the study and take health education, a training booklet prepared by the researchers on healthy lifestyle behavior changes will be given to the participants.
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training booklet prepared by the researchers on healthy lifestyle behavior changes
Description: After the participants enrolled in the study and take health education, a training booklet prepared by the researchers on healthy lifestyle behavior changes will be given to the participants.
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 6 month follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test, intermediate follow-up test (3 months), and post-test (6 months).
Study NCT05390931 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6 month follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test, intermediate follow-up test (3 months), and post-test (6 months).
Study NCT04879225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco e-liquids
Description: Marketplace includes tobacco flavored e-liquids
Study NCT04879225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Menthol and Tobacco e-liquids
Description: Marketplace includes menthol and tobacco flavored e-liquids
Study NCT04879225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mint, Menthol and Tobacco e-liquids
Description: Marketplace includes mint, menthol and tobacco flavored e-liquids
Study NCT04879225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: All e-liquid flavors
Description: Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids
Study NCT05449769 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eNutriCardio personalised nutrition advice
Description: eNutriCardio is a web-based app that administers an FFQ and delivers PN advice to the user. The advice is generated from their responses in the FFQ and considers their sex so the reports are unique to each participant. This report (referred to as a 'healthy eating report') will also include an interactive component, allowing the participant to reflect on the advice received and set personal healthy eating goals to motivate behaviour change. The messages presented in the report have been developed by the eNutriCardio Team, including a registered dietitian and registered nutritionist, are in line with UK dietary guidelines (primarily the EatWell Guide), and promote a Mediterranean-style diet (in line with NICE guidance). Therefore, the advice builds on the generalised advice given during the usual NHS CR programme.
Study NCT06357312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hip trochanteric nail
Description: hip trochanteric nail with and without distal interlocking screw
Study NCT06223152 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: parental support
Description: parental support
Study NCT05706350 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine
Study NCT05706350 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine
Study NCT05135819 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cyber School for Grandparents
Description: Educational program for secondary school students to become cyber tutors for their grandparents or for senior citizens, who are interested to learn new digital use and skills.
Study NCT04773509 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral block
Description: Randomly selected patients of the PVB group are performed PVB with 0.2% ropivacaine on both sides.
Study NCT05250206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myopia control lens
Description: Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.
Study NCT04792489 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: zamtocabtagene autoleucel (MB-CART2019.1)
Description: Chimeric antigen receptor (CAR) T cell therapy
Study NCT04792489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Lymphodepleting chemotherapy
Study NCT04792489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Lymphodepleting chemotherapy
Study NCT04792489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Lymphodepleting chemotherapy
Study NCT05706350 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (2g per day)
Description: Participants have to consume 4 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 2g daily
Study NCT05706350 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (3g per day)
Description: Participants have to consume 6 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 3g daily
Study NCT05706350 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (4g per day)
Description: Participants have to consume 8 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 4g daily
Study NCT05706350 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control soft chews
Description: Participants have to consume 6 control soft chews per day that does not contain plant stanols
Study NCT05026801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin plus hydroxychloroquine
Description: All patients will receive active comparator. One group will receive placebo on D1-3 followed by active comparator D4-9, while the other group will receive active comparator D1-6 followed by placebo D7-9.
Study NCT05026801 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Azithromycin plus hydroxychloroquine
Description: All patients will receive active comparator. One group will receive placebo on D1-3 followed by active comparator D4-9, while the other group will receive active comparator D1-6 followed by placebo D7-9.
Study NCT04996745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tablet-based educational intervention
Description: POSNA's Orthokids website and the article on pediatric forearm fracture will be provided on a tablet. The article provided has two separate tabs, labeled Condition and FAQs, that caregivers will be able to read through. Those who speak Spanish will have the Spanish translated version of Orthokids.
Study NCT05036330 — intervention group
Intervention type: OTHER
Intervention: Clinical Evaluation
Description: Undergo speech and swallow evaluation
Study NCT05036330 — intervention group
Intervention type: PROCEDURE
Intervention: Physical Examination
Description: Undergo examination of TEP and laryngectomy stoma
Study NCT05036330 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete questionnaires
Study NCT05036330 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT05810467 — intervention group
Intervention type: OTHER
Intervention: Active Surveillance
Description: Active surveillance (AS) is an accepted management strategy for men diagnosed with low risk PrCa, generally defined as PSA \<10ng/ml and Gleason score of ≤6 and clinical stage T1 to T2a. Occasionally, a minority of men with Gleason 3+4 disease are included, though majority of those included in AS studies have Gleason 3+3 disease or less.~Men in AS studies have repeated biopsies based on various criteria including PSA velocity, repeat biopsy at set time points and change noted on digital rectal examination (DRE), biopsy or MRI imaging. Progression of disease has been defined in various ways in different studies, generally, using criteria of Gleason upgrade to greater than Gleason 3+3, evidence of Gleason 4 or Gleason 5 disease, >50% involvement of any one biopsy core, and greater than 2 cores positive on repeat biopsy. Percentages of men on AS who have upgrade on repeat biopsy have been found to be 19-34%; this may differ in our cohort of men with increased genetic risk for PrCa.
Study NCT05553236 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Targeted next-generation sequencing
Description: During intervention periods, an additional patient sample derived from routinely collected specimens will be processed by a local technician. Extracted DNA extracted from these samples will be batched on a regular basis for targeted deep sequencing. Sequencing results will be regularly transmitted to a clinical advisory committee.
Study NCT06120842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost Implant System (High Dose)
Description: Bimatoprost Implant System (High Dose) used in combination with the SpyGlass IOL
Study NCT06120842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bimatoprost Implant System (Low Dose)
Description: Bimatoprost Implant System (Low Dose) used in combination with the SpyGlass IOL
Study NCT06120842 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol Maleate Ophthalmic Solution, 0.5%
Description: Timolol Maleate Ophthalmic Solution 0.5% BID
Study NCT06120842 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOL
Description: Commercially Available Aspheric Monofocal Non-Yellow Chromophore Intraocular Lens
Study NCT06120842 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpyGlass IOL
Description: SpyGlass Intraocular Lens
Study NCT06317909 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: allergen challenge
Description: Patients will undergo inhaled allergen challenge followed by different measures like MRI and induced sputum. At least 4 weeks later patients will undergo segmental allergen challenge followed by different measures like bronchoalveolar lavage.
Study NCT06396325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tales from the Magic Keep™
Description: Exergame targeting upper limb and trunk movement designed for use on the Microsoft Azure Kinect Dose: At least 3 times a week for 20 minutes over 8 weeks (8 hours total) Continue with regularly accessed physical activities and rehabilitation services
Study NCT06396325 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: •Continue with regularly accessed physical activities and rehabilitation services
Study NCT05229705 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: Participants in this exercise group will receive progressive resistance training.
Study NCT06463730 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Serious games
Description: Custom games played using the Equio system, non-custom Wii Fit games played using the Nintendo Wii Balance Board
Study NCT05877768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Photon Counting Detector Coronary Computed Tomography Angiography
Description: Clinically indicated Photon Counting Detector Coronary Computed Tomography Angiography for the suspicion of coronary artery disease or the progression thereof.
Study NCT05920278 — intervention group
Intervention type: DEVICE
Intervention: Pulse oximeter
Description: Devices (2) were placed on the finger and the fingertip. Blood samples were taken at each stable level of oxygenation.
Study NCT05404451 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization
Description: Using the Technique of Mulligan Mobilization
Study NCT05404451 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mckenzie Exercises
Description: Using Mckenzie Exercises
Study NCT05555927 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation is an non-invasive brain stimulation that is proposed as a possible interventional tool for major depressive disorder. tDCS device that this study used is from Neuroelectrics, Starstim 8, USA.
Study NCT04281940 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter implantation of chordal repair system
Description: Implantation of anchor via transcatheter delivery system to delivery chordal repair system tethering the mitral leaflets to the ventricle
Study NCT05555927 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation is an non-invasive brain stimulation that is proposed as a possible interventional tool for major depressive disorder. tDCS device that this study used is from Neuroelectrics, Starstim 8, USA.
Study NCT06013111 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intravenous infusion anti-CEA-CAR-T cell
Description: Anti-CEA-CAR-T cell is administered as a single intravenous infusion. Follow-up infusions are based on the investigator's decision.The dose group to be infusion was 0.3×10\^7 CAR-T cells/kg, 1×10\^7 CAR-T cells/kg, and 3×10\^7 CAR-T cells/kg based on the 3+3 dose escalation principle. The infusion dose refers to the number of CAR-positive cells.
Study NCT06643091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nintedanib
Description: Nintedanib150 mg twice a day for 6 months Or Nintedanib 100mg twice a day in case of dose adjustment Oral route (during meals)
Study NCT06641609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dose-Escalation (Phase Ia) CFT8919 capsule
Description: Phase 1a，enrolled, eligible patients receive CFT8919 150-900mg twice daily.
Study NCT06641609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dose-Expansion (Phase Ib) CFT8919 capsule
Description: Phase 1b，enrolled, eligible patients receive CFT8919 RP2D twice daily.
Study NCT06641609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cohort-Expansion (Phase Ic) CFT8919 capsule
Description: Phase 1c，enrolled, eligible patients receive CFT8919 RP2D twice daily.
Study NCT06010719 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: oral azithromycin (20 mg/kg, single directly observed dose, oral suspension),
Study NCT06010719 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Standard of Care. A 7-day, twice-daily course of amoxicillin will be offered as a syrup to children (80 mg/kg divided into twice-daily doses, estimated with weight-based dosing).
Study NCT06010719 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A 7-day, twice-daily course of placebo will be offered as a syrup to children (80 mg/kg divided into twice-daily doses, estimated with weight-based dosing).
Study NCT06320782 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calorie restriction and balanced distribution of macronutrients
Description: Progressive reduction of 500 to 1000 calories from the usual food intake or the recommendation of 20 calories/kg of current weight/day and distribution of macronutrients: 5% of carbohydrates, 2% of proteins and 3% of fats
Study NCT06320782 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calorie restriction and low-carbohydrate diet
Description: Reduction in carbohydrate consumption and an increase in fat and protein intake, with the following proportions: 45% fat, 20% protein and 35% carbohydrate
Study NCT06320782 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calorie restriction and low-fat diet
Description: Restriction of fat consumption and an increase in carbohydrate consumption, with the following proportions: 20% fat, 15% protein and 65% carbohydrate
Study NCT06320782 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collective nutritional guidance
Description: Recommendations of the Food Guide for the Brazilian Population: limitation of the intake of foods with high energy density from fats and simple carbohydrates; substitution of saturated fats for unsaturated fats; exclusion of trans fat from the diet; increasing fruit and vegetable consumption to a daily minimum of 400g; increased consumption of high-fibre foods and limiting the consumption of sugars and salt.
Study NCT05826626 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MindLenses Professional
Description: MindLenses professional's device combines the prismatic adaptation (PA) procedure with the administration of serious games (SG) for cognitive training using a tablet
Study NCT06611150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: All participants enrolled in the study will be treated with nab-paclitaxel during radical radiotherapy following induction chemotherapy. The doses are increased progressively (180 mg/m², 200 mg/m², 230 mg/m², and 260 mg/m²).
Study NCT06616805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: treadmill
Description: Treadmill JAGUAR treadmill:( T900, China) motorized treadmill model (T900) motor power (6.OHP) input voltage (AC220-240 V, 50Hz) speed range (1-20KM/H), inclination range (1-15%) was used for exercise treatment
Study NCT06616389 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: ODX (Osteodex)
Description: Multi-center, prospective, open-label, ascending dose study to evaluate safety and biological efficacy of up to 3 dose levels of ODX.
Study NCT06617663 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EMDR
Description: Eye Movement Desensitization and Reprocessing (EMDR) is a therapy designed to alleviate the distress associated with traumatic memories.
Study NCT06617663 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EMDR
Description: Eye Movement Desensitization and Reprocessing (EMDR) is a therapy designed to alleviate the distress associated with traumatic memories.
Study NCT06617663 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ACT
Description: Acceptance and Commitment Therapy (ACT) is an action-oriented approach to psychotherapy that stems from traditional behavior therapy and cognitive behavioral therapy. Clients learn to stop avoiding, denying, and struggling with their inner emotions and, instead, accept that these deeper feelings are appropriate responses to certain situations and should not prevent them from moving forward in their lives. The ACT Your Way method is specifically designed for young people.
Study NCT06617663 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT
Description: Acceptance and Commitment Therapy (ACT) is an action-oriented approach to psychotherapy that stems from traditional behavior therapy and cognitive behavioral therapy. Clients learn to stop avoiding, denying, and struggling with their inner emotions and, instead, accept that these deeper feelings are appropriate responses to certain situations and should not prevent them from moving forward in their lives. The ACT Your Way method is specifically designed for young people.
Study NCT06675890 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: serum homocysteine
Description: serum homocysteine is associated with atherosclerosis and vascular diseases.
Study NCT06674421 — intervention group
Intervention type: OTHER
Intervention: Reliability Analyses
Description: For the reliability analysis test-retest method will use. There will be a one-week break between the first test and the retest.
Study NCT06615804 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It's primarily used to treat depression, especially in patients who haven't responded well to traditional treatments like medications or psychotherapy. The most common target is the dorsolateral prefrontal cortex, a region often underactive in people with depression. The magnetic pulses stimulate or inhibit brain activity in the targeted area. This is believed to help reset or correct patterns of neural activity associated with depression and other psychiatric disorders. TMS represents an alternative for those struggling with depression, offering a non-invasive approach with relatively few side effects and significant potential benefits
Study NCT06679036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-2189
Description: HRS-2189
Study NCT06203379 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular Exercise Training
Description: Neuromuscular Exercise Training
Study NCT06203379 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control exercise
Description: Exercise Training